These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 20609568

  • 1. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
    Kanayama A, Iyoda T, Matsuzaki K, Saika T, Ikeda F, Ishii Y, Yamaguchi K, Kobayashi I.
    Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
    [Abstract] [Full Text] [Related]

  • 2. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005--the new 'MRSAs'?
    Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, Milch H, Füzi M.
    J Antimicrob Chemother; 2008 Nov; 62(5):978-85. PubMed ID: 18667450
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regional Spread of CTX-M-2-Producing Proteus mirabilis with the Identical Genetic Structure in Japan.
    Kato K, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S.
    Microb Drug Resist; 2017 Jul; 23(5):590-595. PubMed ID: 27834610
    [Abstract] [Full Text] [Related]

  • 7. Distribution and antimicrobial susceptibility profile of extended-spectrum β-lactamase-producing Proteus mirabilis strains recently isolated in Japan.
    Kanayama A, Kobayashi I, Shibuya K.
    Int J Antimicrob Agents; 2015 Feb; 45(2):113-8. PubMed ID: 25182712
    [Abstract] [Full Text] [Related]

  • 8. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G, Costello M, Pitout JD.
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [Abstract] [Full Text] [Related]

  • 9. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
    Yong D, Lim YS, Roh KH, Choi YS, Park DY, Yum JH, Kim JM, Lee K, Chong Y.
    Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
    Fernández A, Gil E, Cartelle M, Pérez A, Beceiro A, Mallo S, Tomás MM, Pérez-Llarena FJ, Villanueva R, Bou G.
    J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
    [Abstract] [Full Text] [Related]

  • 13. Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
    Ho PL, Ho AY, Chow KH, Wong RC, Duan RS, Ho WL, Mak GC, Tsang KW, Yam WC, Yuen KY.
    J Antimicrob Chemother; 2005 Jun; 55(6):840-5. PubMed ID: 15857942
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology of Escherichia coli producing extended-spectrum {beta}-lactamases in Lugo (Spain): dissemination of clone O25b:H4-ST131 producing CTX-M-15.
    Blanco M, Alonso MP, Nicolas-Chanoine MH, Dahbi G, Mora A, Blanco JE, López C, Cortés P, Llagostera M, Leflon-Guibout V, Puentes B, Mamani R, Herrera A, Coira MA, García-Garrote F, Pita JM, Blanco J.
    J Antimicrob Chemother; 2009 Jun; 63(6):1135-41. PubMed ID: 19351692
    [Abstract] [Full Text] [Related]

  • 15. Epidemiology of Escherichia coli, Klebsiella species, and Proteus mirabilis strains producing extended-spectrum β-lactamases from clinical samples in the Kinki Region of Japan.
    Nakamura T, Komatsu M, Yamasaki K, Fukuda S, Miyamoto Y, Higuchi T, Ono T, Nishio H, Sueyoshi N, Kida K, Satoh K, Toda H, Toyokawa M, Nishi I, Sakamoto M, Akagi M, Nakai I, Kofuku T, Orita T, Wada Y, Zikimoto T, Koike C, Kinoshita S, Hirai I, Takahashi H, Matsuura N, Yamamoto Y.
    Am J Clin Pathol; 2012 Apr; 137(4):620-6. PubMed ID: 22431539
    [Abstract] [Full Text] [Related]

  • 16. Dissemination of cefotaxime-M-producing Escherichia coli isolates in poultry farms, but not swine farms, in China.
    Li J, Ma Y, Hu C, Jin S, Zhang Q, Ding H, Ran L, Cui S.
    Foodborne Pathog Dis; 2010 Nov; 7(11):1387-92. PubMed ID: 20583961
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
    Briñas L, Lantero M, de Diego I, Alvarez M, Zarazaga M, Torres C.
    J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
    [Abstract] [Full Text] [Related]

  • 18. Prevalence and resistance patterns of extended-spectrum and AmpC β-lactamase in Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, and Salmonella serovar Stanley in a Korean tertiary hospital.
    Park SD, Uh Y, Lee G, Lim K, Kim JB, Jeong SH.
    APMIS; 2010 Oct; 118(10):801-8. PubMed ID: 20854475
    [Abstract] [Full Text] [Related]

  • 19. A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres.
    Adler A, Baraniak A, Izdebski R, Fiett J, Gniadkowski M, Hryniewicz W, Salvia A, Rossini A, Goossens H, Malhotra S, Lerman Y, Elenbogen M, Carmeli Y, MOSAR WP5 & WP2 study groups.
    Clin Microbiol Infect; 2013 Feb; 19(2):E51-8. PubMed ID: 23210906
    [Abstract] [Full Text] [Related]

  • 20. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
    Kim JY, Park YJ, Kim SI, Kang MW, Lee SO, Lee KY.
    J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.